Why Donaldson (DCI) is a Top Value Stock for the Long-Term

Zacks Investment Research identifies Donaldson (DCI), a filtration systems manufacturer, as a top long-term value stock, assigning it a Zacks Rank #2 (Buy) and a B grade for both its VGM and Value Style Scores, underpinned by a 19.38 forward P/E and recent upward earnings estimate revisions for FY2025. This recommendation leverages Zacks' proprietary Style Scores (Value, Growth, Momentum), which, when combined with the Zacks Rank, aim to pinpoint stocks with high outperformance potential, exemplified by the +23.75% average annual return for #1 Rank stocks since 1988.

Analysis

Donaldson Company, Inc. (DCI) is presented as a compelling value investment based on its favorable positioning within the Zacks rating framework. The company holds a Zacks Rank of #2 (Buy), complemented by a 'B' grade for both its overall VGM (Value, Growth, Momentum) Score and its specific Value Style Score. This positive assessment is quantitatively supported by a forward P/E ratio of 19.38, which is highlighted as an attractive valuation metric. The bullish outlook is further reinforced by positive momentum in analyst sentiment; for fiscal 2025, one analyst has revised earnings estimates upward in the last 60 days, lifting the Zacks Consensus Estimate by $0.01 to $3.67 per share. Furthermore, DCI has a demonstrated history of operational execution, consistently beating earnings estimates with an average surprise of +2.5%. The combination of these factors—a strong quantitative rank, appealing valuation, and positive earnings revisions—underpins the thesis that DCI is a well-positioned stock according to this specific analytical model.

Key Decisions for Investors

• Given the Zacks #2 (Buy) rank and strong 'B' grade for value, investors with a value-oriented strategy should consider DCI as a potential addition to their portfolio, supported by its forward P/E of 19.38.
• The investment case is heavily predicated on positive earnings estimate revisions; therefore, it is critical to monitor for continued upward revisions to the consensus estimate, as a reversal could weaken the stock's quantitative appeal.
• Investors should note that the recommendation is based on a proprietary model that emphasizes factors predicting 30-day outperformance, and should align this with their own investment horizon and risk tolerance.